IDS Pharmacy — Milwaukee, Wisconsin

IDS Pharmacy is a clinical research site located in Milwaukee, Wisconsin, United States 53226.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

IDS Pharmacy has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations.

Sponsors: Taiho Oncology, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for IDS Pharmacy?

IDS Pharmacy has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has IDS Pharmacy conducted?

IDS Pharmacy has 1 clinical trials on record, with 1 currently active. Their work covers Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations.

Is IDS Pharmacy accredited by Crixeo Health?

IDS Pharmacy has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about IDS Pharmacy?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.